全文获取类型
收费全文 | 2728篇 |
免费 | 183篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 116篇 |
妇产科学 | 67篇 |
基础医学 | 203篇 |
口腔科学 | 242篇 |
临床医学 | 321篇 |
内科学 | 644篇 |
皮肤病学 | 11篇 |
神经病学 | 263篇 |
特种医学 | 86篇 |
外科学 | 313篇 |
综合类 | 83篇 |
一般理论 | 1篇 |
预防医学 | 197篇 |
眼科学 | 52篇 |
药学 | 217篇 |
中国医学 | 2篇 |
肿瘤学 | 95篇 |
出版年
2021年 | 43篇 |
2020年 | 26篇 |
2019年 | 53篇 |
2018年 | 44篇 |
2017年 | 43篇 |
2016年 | 36篇 |
2015年 | 46篇 |
2014年 | 69篇 |
2013年 | 74篇 |
2012年 | 138篇 |
2011年 | 134篇 |
2010年 | 90篇 |
2009年 | 60篇 |
2008年 | 92篇 |
2007年 | 98篇 |
2006年 | 110篇 |
2005年 | 107篇 |
2004年 | 73篇 |
2003年 | 98篇 |
2002年 | 72篇 |
2001年 | 80篇 |
2000年 | 87篇 |
1999年 | 83篇 |
1998年 | 32篇 |
1997年 | 27篇 |
1996年 | 23篇 |
1994年 | 25篇 |
1993年 | 24篇 |
1992年 | 50篇 |
1991年 | 61篇 |
1990年 | 61篇 |
1989年 | 58篇 |
1988年 | 52篇 |
1987年 | 62篇 |
1986年 | 59篇 |
1985年 | 60篇 |
1984年 | 32篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1980年 | 35篇 |
1979年 | 47篇 |
1978年 | 44篇 |
1976年 | 20篇 |
1975年 | 21篇 |
1974年 | 32篇 |
1973年 | 26篇 |
1972年 | 37篇 |
1971年 | 22篇 |
1970年 | 24篇 |
1969年 | 24篇 |
排序方式: 共有2918条查询结果,搜索用时 453 毫秒
81.
Refaat MM Tanaka T Kormos RL McNamara D Teuteberg J Winowich S London B Simon MA 《Journal of cardiac failure》2012,18(2):140-145
BackgroundImplantable cardioverter-defibrillators (ICDs) reduce mortality in heart failure (HF). In patients requiring a ventricular assist device (VAD), the benefit from ICD therapy is not well established. The aim of this study was to define the impact of ICD on outcomes in VAD-supported patients.Methods and ResultsWe reviewed data for consecutive adult HF patients receiving VAD as a bridge to transplantation from 1996 to 2003. The primary outcome was survival to transplantation. A total of 144 VADs were implanted [85 left ventricular (LVAD), 59 biventricular (BIVAD), mean age 50 ± 12 years, 77% male, left ventricular ejection fraction 18 ± 9%, 54% ischemic]. Mean length of support was 119 days (range 1–670); 103 patients (72%) survived to transplantation. Forty-five patients had an ICD (33 LVAD, 12 BIVAD). More LVAD patients had an appropriate ICD shock before implantation than after (16 vs 7; P = .02). There was a trend toward higher shock frequency before LVAD implant than after (3.3 ± 5.2 vs 1.1 ± 3.8 shocks/y; P = .06). Mean time to first shock after VAD implant was 129 ± 109 days. LVAD-supported patients with an ICD were significantly more likely to survive to transplantation [1-y actuarial survival to transplantation: LVAD: 91% with ICD vs 57% without ICD (log-rank P = .01); BIVAD: 54% vs 47% (log-rank P = NS)]. An ICD was associated with significantly increased survival in a multivariate model controlling for confounding variables (odds ratio 2.54, 95% confidence interval 1.04–6.21; P = .04).ConclusionsShock frequency decreases after VAD implantation, likely owing to ventricular unloading, but appropriate ICD shocks still occur in 21% of patients. An ICD is associated with improved survival in LVAD-supported HF patients. 相似文献
82.
Cooper LT Mather PJ Alexis JD Pauly DF Torre-Amione G Wittstein IS Dec GW Zucker M Narula J Kip K McNamara DM;IMAC Investigators 《Journal of cardiac failure》2012,18(1):28-33
BackgroundWhether myocardial recovery occurs more frequently in peripartum cardiomyopathy (PPCM) than in recent onset cardiomyopathies in men and nonperipartum women has not been prospectively evaluated. This was examined through an analysis of outcomes in the Intervention in Myocarditis and Acute Cardiomyopathy 2 (IMAC2) registry.Methods and ResultsIMAC2 enrolled 373 subjects with recent onset nonischemic dilated cardiomyopathy. Left ventricular ejection fraction (LVEF) was assessed at entry and 6 months, and subjects followed for up to 4 years. Myocardial recovery was compared between men (group 1), nonperipartum women (group 2) and subjects with PPCM (group 3). The cohort included 230 subjects in group 1, 104 in group 2, and 39 in group 3. The mean LVEF at baseline in groups 1, 2, and 3 was 0.23 ± 0.08, 0.24 ± 0.08, and 0.27 ± 0.07 (P = .04), and at 6 months was 0.39 ± 0.12, 0.42 ± 0.11, and 0.45 ± 0.14 (P = .007). Subjects in group 3 had a much greater likelihood of achieving an LVEF >0.50 at 6 months than groups 1 or 2 (19 %, 34%, and 48% respectively, P = .002).ConclusionsProspective evaluation confirms myocardial recovery is greatest in women with PPCM, poorest in men, and intermediate in nonperipartum women. On contemporary therapy, nearly half of women with PPCM normalize cardiac function by 6 months. 相似文献
83.
Fiona McNicholas Barbara Dooley Niamh McNamara Ruth Lennon 《European eating disorders review》2012,20(5):355-362
This paper considers the impact of pubertal status and pubertal timing on disordered eating in Irish adolescents. 1190 boys and 1841 girls completed the Eating Attitudes Test‐26, the Eating Disorder Inventory‐III and self‐report measures of pubertal status and pubertal timing. Regarding pubertal status, greater maturity in girls was associated with increased overall eating concerns, higher drive for thinness and higher levels of body dissatisfaction. In boys, greater maturity was associated with lower drive for thinness and lower body dissatisfaction. Regarding pubertal timing, early‐maturing girls showed the most eating concerns, the highest drive for thinness, scored highest on bulimic symptoms and were the most dissatisfied with their bodies. In contrast, late‐maturing boys had more bulimic symptoms and more dissatisfaction with their bodies than on‐time peers. The findings suggest that puberty itself is a risk factor for disordered eating for girls rather than boys; however, pubertal timing is a risk factor for both. Copyright © 2012 John Wiley & Sons, Ltd and Eating Disorders Association. 相似文献
84.
85.
86.
The aim of this study was to evaluate soft tissue differences between Turkish and North American adults by comparing two sample populations with ideal occlusion and well-balanced faces. Lateral cephalometric radiographs of 117 Anatolian Turkish adults (65 female and 52 male, mean age: 23.9 ± 2.8 years) were compared with a sample of 116 adults of European-American ancestry (64 female and 52 male, mean age: 25.0 ± 6.8 years). The cephalometric analyses of Holdaway, Epker, and Legan and Burstone were performed using Dolphin Image Software 9.0. Thirty-two measurements (27 linear and 5 angular) were analysed. For statistical evaluation, independent samples t-tests were performed. Distinct differences were found between the two samples in facial convexity, upper lip position and length, lower lip position, chin prominence, and chin thickness. Vertical proportional findings were similar between groups. Ethnic differences were found between Turkish and North American adults in the soft tissue profile. It is appropriate to consider these differences during routine diagnosis and treatment planning of a Turkish patient or an American patient of European ancestry. 相似文献
87.
88.
89.
90.
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents 总被引:2,自引:1,他引:1 下载免费PDF全文
Flynn PM Rodman J Lindsey JC Robbins B Capparelli E Knapp KM Rodriguez JF McNamara J Serchuck L Heckman B Martinez J;PACTG P Team 《Antimicrobial agents and chemotherapy》2007,51(10):3516-3522
Zidovudine (ZDV) and lamivudine (3TC) metabolism to triphosphates (TP) is necessary for antiviral activity. The aims of this study were to compare ZDV-TP and 3TC-TP concentrations in adolescents receiving twice daily (BID) and once daily (QD) regimens and to determine the metabolite concentrations of ZDV and 3TC during chronic therapy on a QD regimen. Human immunodeficiency virus-infected patients (12 to 24 years) taking ZDV (600 mg/day) and 3TC (300 mg/day) as part of a highly active antiretroviral therapy regimen received QD and BID regimens of ZDV and 3TC for 7 to 14 days in a crossover design. Serial blood samples were obtained over 24 h on the QD regimen. Intracellular mono-, di-, and triphosphates for ZDV and 3TC were measured. The median ratio of BID/QD for ZDV-TP predose concentrations was 1.28 (95% confidence interval [CI] = 1.00 to 2.45) and for 3TC-TP was 1.12 (95% CI = 0.81 to 1.96). The typical population estimated half-lives (+/- the standard error of the mean) were 9.1 +/- 0.859 h for ZDV-TP and 17.7 +/- 2.8 h for 3TC-TP. Most patients had detectable levels of the TP of ZDV (24 of 27) and 3TC (24 of 25) 24 h after dosing, and half-lives on a QD regimen were similar to previously reported values when the drugs were given BID. Lower, but not significantly different, concentrations of ZDV-TP were demonstrated in the QD regimen compared to the BID regimen (P = 0.056). Although findings were similar between the BID and QD groups, the lower concentrations of ZDV and the number of patients below the level of detection after 24 h suggests that ZDV should continue to be administered BID. 相似文献